ConductScience.org, home

Comparison · NCT01898221-deaths

Standard Catheter Ablation Patient Group vs Vein of Marshall and Standar Procedure: deaths from any cause

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Standard Catheter Ablation Patient Group vs Vein of Marshall and Standar Procedure: deaths from any cause. Trial comparisons, record NCT01898221-deaths. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01898221-deaths

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.01270.003480.045wilson
Risk in group 20.02160.008440.0543wilson
Risk difference, group 1 minus group 2-0.00896-0.04290.0259newcombe hybrid score
Risk ratio, group 1 over group 20.5850.1093.15log
Odds ratio, group 1 over group 20.580.1053.21log
Number needed to treat, for one fewer death from any cause on Standard Catheter Ablation Patient Group than on Vein of Marshall and Standar Procedure112from the risk difference intervalthe interval includes no difference

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Standard Catheter Ablation Patient Group
Patients will have a standard procedure ablation~Ablation: The doctor will perform only the standard procedure. Throughout the procedure, the researchers will document the following information for ALL patients: measurements such as whether the treatment was successful or unsuccessful, X-ray exposure time, procedure time, whether there were any complications, and other general procedural measurements.
2158EG000
Group 2Vein of Marshall and Standar Procedure
The doctor will inject Ethanol through a balloon catheter into the VOM~Ethanol: We enter the CS with a sheath advanced from the right internal jugular vein. A sub-selector catheter with a \~90° angle at the tip (typically, a left internal mammary artery angioplasty guide catheter) is advanced through the CS sheath with its tip pointing superiorly and posteriorly.
4185EG001

Harm

What it counts
Total, all-cause mortality
Time frame
AE data collected for 1 year post ablation. This was FU period for patients enrolled in the trial.

Source ClinicalTrials.gov

Trial

Title
Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
NCT number
NCT01898221
Phases
PHASE3
Conditions
Ventricular Tachycardia, Atrial Fibrillation
Interventions
Ethanol, Ablation
Lead sponsor
The Methodist Hospital Research Institute
Results first posted
2025-08-21

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT01898221-deaths